Ying Luo

498 total citations
27 papers, 290 citations indexed

About

Ying Luo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ying Luo has authored 27 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Ying Luo's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Ying Luo is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Ying Luo collaborates with scholars based in China, United States and Canada. Ying Luo's co-authors include Bo Lundbäck, Weifeng Wu, Jing Zhang, Madar Talibov, Mary Ann Lumsden, Catherine M. Hawrylowicz, Bright I. Nwaru, Panagiotis Anagnostis, Aziz Sheikh and Maya B. Mathur and has published in prestigious journals such as Chemical Engineering Journal, International Journal of Molecular Sciences and PLoS Medicine.

In The Last Decade

Ying Luo

25 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Luo China 10 69 59 55 51 40 27 290
Alessandra Alves Thole Brazil 14 59 0.9× 74 1.3× 115 2.1× 26 0.5× 28 0.7× 34 429
Hung-An Chen Taiwan 11 35 0.5× 20 0.3× 83 1.5× 23 0.5× 22 0.6× 23 327
Simone Nunes de Carvalho Brazil 14 92 1.3× 73 1.2× 130 2.4× 33 0.6× 15 0.4× 30 378
Alexander Li United States 9 73 1.1× 45 0.8× 101 1.8× 13 0.3× 88 2.2× 14 347
Răzvan Ciortea Romania 14 39 0.6× 16 0.3× 63 1.1× 13 0.3× 28 0.7× 66 652
Satoshi Akabame Japan 10 139 2.0× 52 0.9× 154 2.8× 75 1.5× 29 0.7× 18 477
Yibo Tang China 9 20 0.3× 14 0.2× 63 1.1× 52 1.0× 31 0.8× 21 292
Alexander Kelly United States 8 47 0.7× 17 0.3× 38 0.7× 18 0.4× 50 1.3× 19 364
Hiroyuki Yajima Japan 12 128 1.9× 72 1.2× 131 2.4× 9 0.2× 30 0.8× 31 361
Eva Honsová Czechia 13 70 1.0× 21 0.4× 83 1.5× 29 0.6× 45 1.1× 32 478

Countries citing papers authored by Ying Luo

Since Specialization
Citations

This map shows the geographic impact of Ying Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Luo more than expected).

Fields of papers citing papers by Ying Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Luo. The network helps show where Ying Luo may publish in the future.

Co-authorship network of co-authors of Ying Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Luo. A scholar is included among the top collaborators of Ying Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Luo. Ying Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cai, Xiaobo, Wen Xie, Yanbin Wang, et al.. (2025). Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
3.
Luo, Ying, et al.. (2025). Hierarchically oriented foam with thermal management performance for hemorrhage control and wound healing. Chemical Engineering Journal. 509. 161052–161052. 3 indexed citations
4.
Zhang, Wenhan, Xiangqian Li, Yujing Zhang, et al.. (2025). Ritlecitinib in alopecia areata: A multicenter retrospective real-world analysis. Journal of the American Academy of Dermatology. 93(4). 1136–1137. 1 indexed citations
5.
Ma, Xiaoxuan, Yiqiong Liu, Jingsi Jiang, et al.. (2025). Polyphenol-synthesized nanoparticles with ALDH3A1 delivery ability for activating estrogen signaling for diabetic wound healing. Chemical Engineering Journal. 521. 166751–166751. 2 indexed citations
6.
Liang, Jing, et al.. (2023). Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 15(1). 1–18. 5 indexed citations
7.
Xu, Xianjun, Yuecheng Guo, Xin Luo, et al.. (2023). Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7‐mediated degradation of TGFβRI. Liver International. 43(11). 2523–2537. 12 indexed citations
9.
Li, Xiaoxiao, Ying Luo, Lingqiao Li, et al.. (2023). In situ-formed micro silk fibroin composite sutures for pain management and anti-infection. Composites Part B Engineering. 260. 110729–110729. 15 indexed citations
10.
Luo, Ying, et al.. (2023). Development of Organs-on-Chips and Their Impact on Precision Medicine and Advanced System Simulation. Pharmaceutics. 15(8). 2094–2094. 9 indexed citations
11.
Zhu, Ying, Ying Luo, Kaili Yang, et al.. (2022). [Predictive value of serum HBV RNA for therapeutic effect of entecavir in patients with chronic hepatitis B].. PubMed. 42(8). 1250–1255.
12.
Luo, Ying, et al.. (2022). Prevalence of Clostridium difficile Infection in the Hematopoietic Transplantation Setting: Update of Systematic Review and Meta-Analysis. Frontiers in Cellular and Infection Microbiology. 12. 801475–801475. 6 indexed citations
13.
Luo, Ying, Maya B. Mathur, Panagiotis Anagnostis, et al.. (2021). Menopausal hormone therapy and women’s health: An umbrella review. PLoS Medicine. 18(8). e1003731–e1003731. 100 indexed citations
14.
Luo, Ying, et al.. (2021). Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment. BMC Cardiovascular Disorders. 21(1). 5–5. 33 indexed citations
15.
Luo, Ying, et al.. (2021). A systematic review and meta-analysis of the correlation between hyperuricemia and thyroid nodules in adults. Gland Surgery. 10(12). 3324–3333. 1 indexed citations
16.
Huang, Qun, et al.. (2020). Modified Maimendong decoction in the treatment of patients with idiopathic pulmonary fibrosis. Medicine. 99(49). e23460–e23460. 5 indexed citations
17.
Guo, Peng, et al.. (2020). Genetically modified endothelial progenitor cells with hNotch1. ICN overexpression display facilitated angiogenesis. Annals of Translational Medicine. 8(20). 1316–1316. 4 indexed citations
18.
Xie, Wenchao, et al.. (2019). <p>The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis</p>. Therapeutics and Clinical Risk Management. Volume 15. 1129–1140. 11 indexed citations
19.
20.
Liu, Yani, Jian Wu, Zhongfang Li, et al.. (2016). Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study. European Journal of Drug Metabolism and Pharmacokinetics. 42(1). 37–48. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026